Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 2
1976 1
1980 3
1981 1
1982 2
1983 3
1984 1
1985 2
1986 5
1987 2
1988 3
1989 8
1990 3
1991 4
1992 3
1993 8
1994 8
1995 7
1996 10
1997 4
1998 10
1999 19
2000 14
2001 20
2002 22
2003 22
2004 30
2005 33
2006 40
2007 38
2008 35
2009 37
2010 52
2011 60
2012 70
2013 72
2014 68
2015 67
2016 73
2017 78
2018 88
2019 114
2020 131
2021 119
2022 112
2023 114
2024 164
2025 182
2026 41

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,751 results

Results by year

Citations

3 articles found by citation matching

Search results

Filters applied: . Clear all
Quoted phrase not found in phrase index: "drug resistance in pneumonia score"
Page 1
Ventilator-associated pneumonia in adults: a narrative review.
Papazian L, Klompas M, Luyt CE. Papazian L, et al. Intensive Care Med. 2020 May;46(5):888-906. doi: 10.1007/s00134-020-05980-0. Epub 2020 Mar 10. Intensive Care Med. 2020. PMID: 32157357 Free PMC article. Review.
Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections. Reported incidences vary widely from 5 to 40% depending on the setting and diagnostic criteria. ...The estimated attributable mortality of VAP is around 10%, with higher mortality ra …
Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections. Reported incidences vary widely from 5 to …
Community-acquired bacterial pneumonia in adults: An update.
Eshwara VK, Mukhopadhyay C, Rello J. Eshwara VK, et al. Indian J Med Res. 2020 Apr;151(4):287-302. doi: 10.4103/ijmr.IJMR_1678_19. Indian J Med Res. 2020. PMID: 32461392 Free PMC article. Review.
Community-acquired pneumonia (CAP) is the prominent cause of mortality and morbidity with important clinical impact across the globe. India accounts for 23 per cent of global pneumonia burden with case fatality rates between 14 and 30 per cent, and Streptococcus …
Community-acquired pneumonia (CAP) is the prominent cause of mortality and morbidity with important clinical impact across the globe. …
Updates on community acquired pneumonia management in the ICU.
Nair GB, Niederman MS. Nair GB, et al. Pharmacol Ther. 2021 Jan;217:107663. doi: 10.1016/j.pharmthera.2020.107663. Epub 2020 Aug 15. Pharmacol Ther. 2021. PMID: 32805298 Free PMC article. Review.
While the world is grappling with the consequences of a global pandemic related to SARS-CoV-2 causing severe pneumonia, available evidence points to bacterial infection with Streptococcus pneumoniae as the most common cause of severe community acquired pneumonia
While the world is grappling with the consequences of a global pandemic related to SARS-CoV-2 causing severe pneumonia, available evi …
Calculated decisions: Drug resistance in pneumonia (DRIP) score.
Dayton J. Dayton J. Emerg Med Pract. 2021 Feb 1;23(Suppl 2):CD4-CD5. Emerg Med Pract. 2021. PMID: 33529518 Review.
A review of the uses and evidence for the DRIP score, which predicts risk for community-acquired pneumonia due to drug-resistant pathogens....
A review of the uses and evidence for the DRIP score, which predicts risk for community-acquired pneumonia due to dr
Discontinuing beta-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Makhloufi S, Mellon G, de Lastours V, Bouchand F, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Perronne C, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia Short Treatment (PTC) Study Group. Dinh A, et al. Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. Lancet. 2021. PMID: 33773631 Clinical Trial.
BACKGROUND: Shortening the duration of antibiotic therapy for patients admitted to hospital with community-acquired pneumonia should help reduce antibiotic consumption and thus bacterial resistance, adverse events, and related costs. ...Randomisation was done using …
BACKGROUND: Shortening the duration of antibiotic therapy for patients admitted to hospital with community-acquired pneumonia should …
Choosing antibiotic therapy for severe community-acquired pneumonia.
Martin-Loeches I, Garduno A, Povoa P, Nseir S. Martin-Loeches I, et al. Curr Opin Infect Dis. 2022 Apr 1;35(2):133-139. doi: 10.1097/QCO.0000000000000819. Curr Opin Infect Dis. 2022. PMID: 35190510 Review.
PURPOSE OF REVIEW: Community-acquired pneumonia (CAP) is known as a major worldwide health concern considering it has been shown to account for 78% of infection-related deaths in the USA. ...There is a need to implement effective policies of de-escalation to avoid antibiot …
PURPOSE OF REVIEW: Community-acquired pneumonia (CAP) is known as a major worldwide health concern considering it has been shown to a …
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance.
Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, Boccia S, Castillo-Polo JA, Magrini E, Garcia-Vello P, Wool E, Gigante V, Duffy E, Cassini A, Huttner B, Pardo PR, Naghavi M, Mirzayev F, Zignol M, Cameron A, Tacconelli E; WHO Bacterial Priority Pathogens List Advisory Group. Sati H, et al. Lancet Infect Dis. 2025 Sep;25(9):1033-1043. doi: 10.1016/S1473-3099(25)00118-5. Epub 2025 Apr 14. Lancet Infect Dis. 2025. PMID: 40245910 Free PMC article.
METHODS: The 2024 WHO BPPL followed a similar approach to the first prioritisation exercise, using a multicriteria decision analysis framework. 24 antibiotic-resistant bacterial pathogens were scored based on eight criteria, including mortality, non-fatal burden, incidence …
METHODS: The 2024 WHO BPPL followed a similar approach to the first prioritisation exercise, using a multicriteria decision analysis framewo …
Community-acquired pneumonia.
Remington LT, Sligl WI. Remington LT, et al. Curr Opin Pulm Med. 2014 May;20(3):215-24. doi: 10.1097/MCP.0000000000000052. Curr Opin Pulm Med. 2014. PMID: 24614242 Review.
PURPOSE OF REVIEW: This review examines the epidemiology, diagnosis, prognosis, treatment and prevention of community-acquired pneumonia (CAP) in adults. RECENT FINDINGS: CAP is a significant cause of morbidity and mortality. Streptococcus pneumoniae is the most com …
PURPOSE OF REVIEW: This review examines the epidemiology, diagnosis, prognosis, treatment and prevention of community-acquired pneumonia
Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital.
Simanjuntak RB, Lie KC, Rumende CM, Abdullah M, Shatri H, Koesnoe S, Nainggolan L, Rizka A. Simanjuntak RB, et al. Acta Med Indones. 2024 Jan;56(1):55-62. Acta Med Indones. 2024. PMID: 38561875 Free article.
BACKGROUND: The incidence of CAP due to Drug-Resistant Pathogen (DRP) requires broad-spectrum antibiotic therapy, Drugs Resistance in Pneumonia (DRIP) score can predict these cases. ...RESULTS: 480 patients met the criteria. There were 331 patie …
BACKGROUND: The incidence of CAP due to Drug-Resistant Pathogen (DRP) requires broad-spectrum antibiotic therapy, Drugs Resistance
The Validation of Drug Resistance in Pneumonia (DRIP) Score in Predicting Infections due to Drug-Resistant Pathogens in Community-acquired Pneumonia at Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Fadrian F, Chen K, Kumalawati J, Rumende CM, Shatri H, Nelwan EJ. Fadrian F, et al. Acta Med Indones. 2021 Oct;53(4):416-422. Acta Med Indones. 2021. PMID: 35027488 Free article.
The purpose of this study is to determine the DRIP performance as an instrument in predicting infections due to drug-resistant pathogens (DRP) in community-acquired pneumonia at Cipto Mangunkusumo Hospital. ...CONCLUSION: The DRIP score demonstr …
The purpose of this study is to determine the DRIP performance as an instrument in predicting infections due to drug-resistant …
1,751 results